Evaluating the usefulness of cardiovascular CT imaging for predicting outcomes
Official title: Clinical Utility and Outcome Prediction of Cardiovascular Computed Tomography (PREDICT-CT)
Run by Insel Gruppe AG, University Hospital Bern · NCT04827316 · Data updated 2026-11-12
This study is trying to see if heart scans can help predict serious health issues and outcomes for patients with heart problems over a 10-year period.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 4200 (estimated) |
| Sponsor | Insel Gruppe AG, University Hospital Bern Academic / other |
| Locations | 1 site (Bern) |
| Status | Recruiting |
| Started | June 1, 2017 |
| Main results expected | February 1, 2031 |
| Study ends | February 1, 2031 |
| Registry record updated | November 4, 2026 |
| Trial ID | NCT04827316 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 years old who are undergoing clinically indicated CCTA.
✕Probably not a fit
Patients who are not undergoing CCTA or are under 18 years old may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study collects and analyzes data from patients undergoing clinically indicated cardiovascular computed tomography angiography (CCTA) over a 10-year period. It aims to explore the relationships between imaging results, laboratory markers, and clinical data to predict mortality and major adverse cardiac events (MACE). By utilizing a comprehensive registry and standard case report forms, the study seeks to integrate findings with international data to enhance understanding of cardiovascular disease. Both retrospective and prospective data will be evaluated to provide a multidimensional view of patient outcomes.
Why it matters
Potential benefit: If successful, this study could improve the prediction of cardiovascular events and enhance patient management strategies.
How similar studies have gone: Other studies have shown promise in using imaging and biomarkers to predict cardiovascular outcomes, making this approach both relevant and potentially impactful.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult individual \>18 years * Undergoing clinically indicated CCTA * Signed informed consent or waiver Exclusion Criteria: * None
Where it's running
-
Department of Cardiology, University Hospital Bern, Inselspital, Bern
Bern, Switzerland Recruiting
Study contacts
- Principal investigator: Christoph Gräni, MD, PhD — Department of Cardiology, University Hospital Bern,
- Study coordinator: Christoph Gräni, MD, PHD
- Email: christoph.graeni@insel.ch
- Phone: +41 31 632 4508
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stratified medicine approach for managing angina without obstructive coronary artery disease
This study is testing if a personalized treatment plan based on a special heart test can help people with angina who don’t have blocked arteries feel better and improve their health.
-
Early LDL-C lowering with evolocumab after ACS to see if it slows plaque progression
This trial tests whether starting evolocumab soon after a heart attack or unstable angina, in addition to standard therapy, reduces non-culprit plaque growth over a year.
-
Registry to track management and outcomes of patients with complex coronary artery disease
This study is tracking how well different treatments for complex coronary artery disease work in patients who have had procedures like stents or bypass surgery.
-
Registry collecting data on cardiac PET and CardioFlux Magnetocardiography for coronary ischemia detection
This study is collecting information from patients who might have coronary ischemia to see if a new heart imaging method can help find this condition better than the standard tests.
-
Registry to evaluate outcomes of coronary artery disease patients treated with specific balloon catheters
This study looks at how well certain drug-coated balloons work for patients with coronary artery disease who have had a specific heart procedure, to see how they help with recovery and overall health.
-
μFR-guided Drug-Coated Balloon Angioplasty vs Angiography-guided Angioplasty in Coronary Artery Disease
This trial tests whether using computational μFR guidance during drug-coated balloon angioplasty is better than standard angiography guidance for people with de novo coronary artery lesions.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.